Renephra

Based in the United Kingdom, Renephra is a startup. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Renephra develops wearable medical devices that use micro-needle technology and negative pressure therapy to non-invasively remove excess fluid and toxins through the skin, aiming to treat fluid overload and chronic oedema as an alternative to dialysis.